dc.contributor.author | Wahyuningrum, Ike | |
dc.contributor.author | Hariyadi, D. M | |
dc.contributor.author | Hendradi, E | |
dc.date.accessioned | 2022-02-23T05:09:48Z | |
dc.date.available | 2022-02-23T05:09:48Z | |
dc.date.issued | 2017-04-20 | |
dc.identifier.issn | 0975-4415 | |
dc.identifier.uri | https://www.myresearchjournals.com/index.php/IJDDT/article/view/10657 | |
dc.identifier.uri | http://repository.unisma.ac.id/handle/123456789/3109 | |
dc.description | [ARCHIVES] Copyright Article from: INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY (MRI Publications Lucknow, Uttar Pradesh, India) | en_US |
dc.description.abstract | Objective: The aim of this research study was to investigate the anti-inflammatory effect of NLC meloxicam. NLC contains
solid and liquid lipid. Monostearin as solid lipid and Miglyol 808 as liquid lipid. Methods : NLC meloxicam was repared
using emulsification methodwith three different lipid ratio. . NLC meloxicam was prepared and characterized for measuring
the pH, viscocity, particle size, and entrapment efficiency. The rat paw edema test was performed to evaluate the antiinflammatory
activity of three formulations NLC meoxicam. Results : based on research result shows that the smaller the
solid lipid concentrations, particle size is the larger, the greater viscosity, thus increasing occlusive NLC to the skin. The
third formula hasthe greatest solid lipid concentration shows the smallest AUC value but once in a statistical test known to
be significantly different from the three formulas. Conclusions : NLC meloxicam showed that it had anti-inflammatory
effectiveness | en_US |
dc.language.iso | en | en_US |
dc.publisher | MRI Publications Lucknow, Uttar Pradesh, India | en_US |
dc.relation.ispartofseries | INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY;Vol.7, Issue 4 | |
dc.subject | NLC | en_US |
dc.subject | meloxicam | en_US |
dc.subject | antiinflammatory | en_US |
dc.subject | paw edema | en_US |
dc.title | Anti-Inflammatory Evaluation of NLC (Nanostructured Lipid Carriers) Meloxicam In-Vivo | en_US |
dc.type | Article | en_US |